Logo

Evotec Signs an Agreement with Sanofi for Novel Drug Development

Share this

Evotec Signs an Agreement with Sanofi for Novel Drug Development

Shots:

  • Sanofi and Evotec launches BRIDGE LAB031- designed to convert academic research into drug discovery candidates for multiple therapeutic areas. BRIDGE is a public-private partnership combining academia- biotech and venture capital into pharma for early-stage projects
  • The companies will focus on development of multiple small molecule programmes through lead optimization for next three years
  • Evotec will develop and generate multiple lead candidates for Sanofi and apply its technologies to the projects for expedited drug discovery and development. Sanofi has an option to acquire development rights of products on expected milestone criteria

Ref: Evotec | Image: Handelsblatt

Click here to­ read the full press release 

Senior Editor

This content piece was prepared by our former Senior Editor. She had expertise in life science research and was an avid reader. For any query reach out to us at connect@pharmashots.com

Share this article on WhatsApp, LinkedIn and Twitter

Join the PharmaShots family of 12000+ subscribers

I accept the Terms and Conditions